Hospital Patients Who Don’t Speak English Had Worse COVID-19 Disease Outcomes
COVID-19 patients who do not speak English faced worse hospital outcomes during the first wave of the pandemic.
COVID-19 patients who do not speak English faced worse hospital outcomes during the first wave of the pandemic.
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).
Despite no reported cases of illness associated with the affected products, all retailers who received these items have been duly informed, and the recall is…
Hospital grades released by Leapfrog reviews state and now metro areas for safety and patient satisfaction.
Detection of E coli bacteria and inorganic arsenic in these products raises significant health concerns.
In a new real-world study, Sanofi and AstraZeneca’s nirsevimab-alip (Beyfortus) demonstrated high efficacy against respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD).
This study monitored viral load in asymptomatic blood donors, unveiling insights into the progression of HEV infections, vital for public health strategies.
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
Study reveals concerning trends from the mosquito-borne disease impacting Canada and the US.
A Centers for Disease Control and Prevention (CDC) investigator offers insights into their investigation of customers receiving vampire facials (a spa cosmetic procedure) and contracting…
The INSPIRE trials find prompts within computerized provider ordering improves antibiotic utilization for pneumonia and urinary tract infections.